Previous 10 | Next 10 |
PARIS and CAMBRIDGE, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities f...
PARIS and CAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “ Nanobiotix ” or the “ Company ”), a late-clinical stage biotechnology company pioneering physics-based approaches to expand t...
2023-11-02 11:54:36 ET More on Nanobiotix Nanobiotix S.A. (NBTX) Q2 2023 Earnings Call Transcript Nanobiotix: At A Crucial Juncture For Data Nanobiotix: French Radiation Enhancer Developer With A Major JNJ Deal Biggest stock movers today: PHG, Pioneer Natural...
PARIS and CAMBRIDGE, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “ Nanobiotix ” or the “ Company ”), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treat...
PARIS and CAMBRIDGE, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “ Nanobiotix ” or the “ Company ”), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treat...
Strategic Collaborator-presented Phase 1 Pancreatic Cancer Data An ongoing Phase 1, collaborator-led study of NBTXR3 in locally advanced pancreatic cancer (LAPC) established a favorable safety profile and recommended dose 23 months median Overall Survival (mOS) observed in 17 ...
2023-10-06 14:07:17 ET More on Industrial Sector A Rising Interest Rate Freight Train Is Coming For The Economy XLI: Industrial Fundamentals Look Great And It's Time To Buy U.S. blocks imports from 3 Chinese companies blamed for forced labor Most manufa...
2023-10-06 13:29:08 ET Gainers: Falcon's Beyond Global (FBYD) +145% . American Oncology Network ( AONC ) +53% . Akso Health Group ( AHG ) +23% . Vigil Neuroscience ( VIGL ) +20% . NuScale Power Corporation ( SMR )...
2023-10-06 08:53:38 ET OMNIQ ( OMQS ) -44% announces pricing of public offering. Wheeler Real Estate Investment Trust ( WHLR ) -21% . ShiftPixy ( PIXY ) -19% . Nanobiotix ( NBTX ) -15% . Aehr Test ( AEHR ) -11% . ...
2023-10-06 06:55:38 ET Related stories Aehr Test Systems (AEHR) Q1 2024 Earnings Call Transcript Exxon Mobil: Just An All Around Solid Company Aehr Test Systems: SiC, GaN And Optical On-Chip Customers Drive Increasing Revenues Exxon close to buying Pioneer Na...
News, Short Squeeze, Breakout and More Instantly...
PARIS and CAMBRIDGE, Mass., June 12, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘ Company ’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities...
Data show favorable safety and feasibility in 68 heavily pre-treated patients with R/M-HNSCC (Intention-to-Treat population; “ITT”) who received RT-activated NBTXR3 followed by anti-PD-1 as a second-or-later line treatment 48% ORR in evaluable anti-PD-1 naïve patients (n=25...
New data from the completed dose escalation part and ongoing expansion part of Study 1100, an ongoing US Phase 1 study evaluating NBTXR3 followed by anti-PD-1 in patients with recurrent or metastatic head and neck cancer (n=68) to be presented by Coordinating Investigator Colette Shen, MD, PhD, a...